E-Selectin

E-Selectin Overview

English NameSelectin EApproved Drugs0
Drugs in Clinical Trials4Target SynonymLECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Leukocyte Endothelial Cell Adhesion Molecule 2,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,Endothelial Adhesion Molecule 1,E-Selectin,E-selection
Highest Development StagePhase 3 Clinical
English NameSelectin E
Target SynonymLECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Leukocyte Endothelial Cell Adhesion Molecule 2,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,Endothelial Adhesion Molecule 1,E-Selectin,E-selection
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StagePhase 3 Clinical

E-Selectin Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (2)Mouse (1)

  • Tag

    His Tag (2)Fc Tag (1)

  • Conjugate

    Unconjugated (3)

E-Selectin Background

E-Selectin is also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), a member of the Selectin family, is a 107-115 kDa cell surface glycoprotein. It is transiently expressed on vascular endothelial cells in response to IL-1β and TNFα. E selectin has a cassette structure: an N-terminal, C-type lectin domain, an EGF (epidermal-growth-factor)-like domain, 6 Sushi domain (SCR repeat) units, a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto). During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury. The local release of cytokines IL-1 and TNF-α by damaged cells induces the over-expression of E-selectin on endothelial cells of nearby blood vessels. E-selectin mediates the adhesion of tumor cells to endothelial cells, by binding to E-selectin ligands expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, natural killer cells or cancer cells. Furthermore, a number of studies have reported that levels of E-Selectin may be elevated in subjects with a variety of pathological conditions.

E-Selectin Synonyms

SELE,RP1-117P20.2,CD62E,ELAM1,ESEL,LECAM2,E-Selectin

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UproleselanGMI-1271; APL-106Phase 3 ClinicalCrescent Biopharma IncCoronavirus Disease 2019 (COVID-19); Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Venous Thrombosis
Details
E-selectin targeting humanized antibody (LifeArc)Phase 1 ClinicalLifearcRespiratory Distress Syndrome, Adult; Sepsis
Details
GMI-1687GMI-1687; APL-108Phase 1 ClinicalCrescent Biopharma IncAnemia, Sickle Cell; Inflammation; Leukemia, Myeloid, Acute
Details
PF-07209326PF-07209326Phase 1 ClinicalPfizer IncAnemia, Sickle Cell
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland